In the US, Doxercalciferol (doxercalciferol systemic) is a member of the drug class vitamins and is used to treat Secondary Hyperparathyroidism.
US matches:
- Doxercalciferol
- Doxercalciferol Capsules
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A11CC08
CAS registry number (Chemical Abstracts Service)
0054573-75-0
Chemical Formula
C28-H44-O2
Molecular Weight
412
Therapeutic Category
Vitamin D analogue
Chemical Names
(5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraene-1alpha,3beta-diol (WHO)
9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1-alpha,3-beta,5Z,7E,22E)-
Foreign Names
- Doxercalciferolum (Latin)
- Doxercalciferol (German)
- Doxercalciferol (French)
- Doxercalciferol (Spanish)
Generic Names
- 1-alpha-Hydroxyergocalciferol (IS)
- 1-alpha-Hydroxyvitamin D2 (IS)
- 1-alpha-OH-D2 (IS)
- 1-Hydroxyergocalciferol (IS)
- BRN 4716774 (IS)
- TSA 870 (IS)
Brand Name
- Hectorol
Genzyme, United States
International Drug Name Search
Glossary
IS | Inofficial Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment